Exponent's client is developing chimeric antigen receptor (CAR) T-cell therapy, a promising treatment for multiple myeloma and non-Hodgkin's lymphoma. However, a potentially life-threatening immune system side-effect — cytokine release syndrome (CRS) — requires monitoring those receiving CAR T-cell therapy in the hospital, which increases healthcare system costs and negatively impacts patients' quality of life.
EXPONENT'S MULTIDISCIPLINARY SOLUTION
Based on the depth of experience in Exponent's Health Sciences, Biomedical Engineering & Sciences, and Biomechanics practices, a client asked us to identify digital health technologies for effective at-home monitoring of CRS and other potential side effects of CAR T-cell therapy.
The client incorporated Exponent's insights for monitoring CAR T-cell therapy recipients using digital health technologies to streamline the treatment process and reduce hospitalizations, improving affordability, equitable access, and outcomes.
What Can We Help You Solve?
We help our life sciences clients thrive by bringing data-driven and evidence-based approaches to pushing the boundaries of what's possible in patient care. Connecting decades of experience across industries, we stay agile and evolve our capabilities to see around corners, anticipate challenges, and mitigate them for our clients.